In HNSCC patients with high EGFR score (> 7), the frequency of EGFR-specific CD8+ T cells was significantly (p < 0.05) increased for both peptides compared to NC and HNSCC patients with a low EGFR score (< 7) (Figure 2). The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.